Novavax Inc. (NASDAQ: NVAX), a biotech company, reported last week that its COVID-19 vaccine has been approved in Japan. Similar permissions have already been reported by the firm in other places. On April 19, Japanese regulatory authorities authorized Novavax’s Nuvaxovid vaccine for use in the main vaccination series as well as as a booster vaccine. …
Heading Towards a Potential Reversal? Novavax Inc. (NVAX) Read More »
Windtree Therapeutics, Inc. (WINT) stock soared 40.01% in the pre-market trading session at the price of $1.40 after reporting topline data from its SEISMiC study. Windtree is advancing numerous next-gen interventions to treat acute pulmonary and cardiovascular diseases. Using the latest clinical, technological, and scientific techniques, WINT is formulating multi-asset compounds with a capacity to …
Windtree Therapeutics, Inc. (WINT) Stock Surged 40.01% Pre-Market, Here’s Why Read More »
Checkmate Pharmaceuticals, Inc. (CMPI) stock soared 326.75% in the pre-market trading session at the price of $10.37 following a definitive deal to be acquired by Regeneron. Checkmate is a clinical-stage biotechnology corporation that develops and commercializes proprietary technology to trigger the immune system against cancerous cells. CMP-001, its product candidate, had designed to activate the …
Checkmate Pharmaceuticals, Inc. (CMPI) Stock Surged 326.75% Pre-Market, Here’s Why Read More »
CBAK Energy Technology, Inc. (CBAT) stock soared 15.70% in the pre-market trading session at the price of $1.40 after reporting its earnings report for the fourth quarter and year 2021. CBAT Q4 2021 Financial Results On 14th April 2022, CBAT published its financial results for the quarter and year ended on 31st December 2021. …
CBAK Energy Technology, Inc. (CBAT) Stock Surged 15.70% Pre-Market, Here’s Why Read More »
iBio, Inc. (IBIO) stock plummeted 10.00% in the pre-market trading session at the price of $0.40 despite no fundamental developments. IBIO Fiscal Q2 2022 Earnings Report On 14th February 2022, IBIO published its financial results for the fiscal second quarter ended 31st December 2021 and delivered business updates. Revenues totaled US$0.2M for Q2 of fiscal …
iBio, Inc. (IBIO) Stock Plunged 10.00% Pre-Market, Here’s Why Read More »
Werewolf Therapeutics, Inc. (HOWL) stock plummeted 10.92% in the current-market trading session at the price of $5.20 following a licensing deal with Jazz Pharmaceuticals. HOWL is an advanced biopharmaceutical firm that develops therapeutics to boost immunity against cancerous cells. The company leverages its PREDATOR technology to develop activated molecules that stimulate innate and adaptive immunity. …
Werewolf Therapeutics, Inc. (HOWL) Stock Plunged 10.92% Current-Market, Here’s Why Read More »
Advent Technologies Holdings, Inc. (ADN) stock soared 75.72% in the current-market trading session at the price of $3.55 following a collaborative deal with Hyundai Motor Company. Development Agreement with Hyundai On 6th April 2022, ADN announced joining a technology assessment, sales, and development deal with Hyundai, a top global automotive plant supplying a range of …
Advent Technologies Holdings, Inc. (ADN) Stock Surged 75.72% Current-Market, Here’s Why Read More »
Mullen Automotive, Inc. (MULN) stock soared 6.27% in the pre-market trading session at the price of $3.05 following the promotion of John Taylor to senior vice president. Mullen is an automotive corporation that is focused on making EVs more affordable and accessible by devising an end-to-end system. The company partners with multiple synergistic firms working …
Mullen Automotive, Inc. (MULN) Stock Surged 6.27% Pre-Market, Here’s Why Read More »
